Related Experiment Video
Updated: Aug 8, 2026
07:17
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations
N L Prigoda1, S Savas, S A Abdalla
1HHT Solutions, Toronto Western Hospital, Toronto, Canada.
Journal of Medical Genetics
|May 13, 2006
Summary
Genetic testing for Hereditary Haemorrhagic Telangiectasia (HHT) identifies mutations in 80% of families. This strategy analyzes ENG, ACVRL1, and MADH4 genes for accurate diagnosis and risk assessment.
Area of Science:
- Genetics
- Molecular Biology
- Medical Diagnostics
Background:
- Hereditary Haemorrhagic Telangiectasia (HHT) is a genetic disorder affecting 1 in 8000 people, characterized by arteriovenous malformations.
- Genetic testing is crucial for identifying individuals at risk and aiding in HHT diagnosis.
Purpose of the Study:
- To outline an optimized strategy for detecting disease-causing mutations in families with a clinical diagnosis of HHT.
- To improve the diagnostic yield of genetic testing for HHT.
Main Methods:
- Employs quantitative multiplex PCR, sequence analysis, and RNA analysis.
- Validates missense mutations using amino acid conservation analysis for ENG and ACVRL1 genes.
- Includes analysis of an ACVRL1 protein structural model and MADH4 gene sequencing if necessary.
Main Results:
- Identified mutations in 155 out of 194 families (80% sensitivity) over eight years.
- Discovered 16 novel mutations, with 94 in ENG (61%), 58 in ACVRL1 (37%), and 3 in MADH4 (2%).
Conclusions:
- Amino acid conservation analysis effectively predicts the impact of ENG and ACVRL1 missense variants on protein function.
- Approximately 20% of families remain unresolved, potentially due to complex mutations or unidentified genes.
